Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Henlius Completes First Dosing in Head-to-Head Study of PD-1 Inhibitor HanSiZhuang
January 30, 2025
Company
Deals
JancsiTech Raises Tens of Millions in Angel Round Led by Yuanbio Venture Capital
January 30, 2025
Company
Drug
FDA Rejects Spectrum’s Poziotinib NDA for NSCLC Treatment
January 30, 2025
Company
Sino Biological to Invest RMB 1 Billion in Beijing Bio-Pharmaceutical Park
January 30, 2025
Company
Drug
Luye Pharma Launches Toludesvenlafaxine in China for Depression Treatment
January 30, 2025
R&D
Hong Kong Researchers Identify New Target for Epilepsy Treatment
January 30, 2025
Company
Drug
Hope Medicine Gains Global Approval for Phase II Trial of HMI-115
January 30, 2025
Company
Deals
Full-Life Technologies Acquires Focus-X Therapeutics to Expand Pipeline
January 30, 2025
Policy / Regulatory
NMPA Launches Electronic Certificates for API and Pharmaceutical Product Exports
January 30, 2025
Company
Deals
I-Mab Partners with Wuxi Diagnostics to Advance Biomarker-Driven Clinical Studies
January 30, 2025
Company
Deals
Trinomab Biotech Raises RMB 750 Million in Pre-IPO Financing Round
January 30, 2025
Company
Alibaba Health Reports 22.9% Revenue Growth in H1 2022
January 30, 2025
1
2
…
1,082
1,083
1,084
1,085
1,086
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?